PT - JOURNAL ARTICLE AU - Jacobs, John J. L. AU - Beekers, Inés AU - Verkouter, Inge AU - Richards, Levi B. AU - Vegelien, Alexandra AU - Bloemsma, Lizan D. AU - Bongaerts, Vera A. M. C. AU - Cloos, Jacqueline AU - Erkens, Frederik AU - Gradowska, Patrycja AU - Hort, Simon AU - Hudecek, Michael AU - Juan, Manel AU - Maitland-van der Zee, Anke H. AU - Velázquez, Sergio Navarro AU - Ngai, Lok Lam AU - Rafiq, Qasim A AU - Sanges, Carmen AU - Tettero, Jesse AU - van Os, Hendrikus J. A. AU - Vos, Rimke C. AU - de Wit, Yolanda AU - van Dijk, Steven TI - A data management system for precision medicine AID - 10.1101/2024.02.09.24302600 DP - 2024 Jan 01 TA - medRxiv PG - 2024.02.09.24302600 4099 - http://medrxiv.org/content/early/2024/02/11/2024.02.09.24302600.short 4100 - http://medrxiv.org/content/early/2024/02/11/2024.02.09.24302600.full AB - Introduction Precision, or personalised medicine has advanced requirements for medical data management systems (MedDMSs). MedDMS for precision medicine should be able to process hundreds of parameters from multiple sites, be adaptable while remaining in sync at multiple locations, real-time syncing to analytics and be compliant with international privacy legislation. This paper describes the LogiqSuite software solution, aimed to support a precision medicine solution at the patient care (LogiqCare), research (LogiqScience) and data science (LogiqAnalytics) level. LogiqSuite is certified and compliant with international medical data and privacy legislations.Method This paper evaluates a MedDMS in five types of use cases for precision medicine, ranging from data collection to algorithm development and from implementation to integration with real-world data. The MedDMS is evaluated in seven precision medicine data science projects in prehospital triage, cardiovascular disease, pulmonology, and oncology.Results The P4O2 consortium uses the MedDMS as an electronic case report form (eCRF) that allows real-time data management and analytics in long covid and pulmonary diseases. In an acute myeloid leukaemia study data from different sources were integrated to facilitate easy descriptive analytics for various research questions. In the AIDPATH project, LogiqCare is used to process patient data, while LogiqScience is used for pseudonymous CAR-T cell production for cancer treatment. In both these oncological projects the data in LogiqAnalytics is also used to facilitate machine learning to develop new prediction models for clinical-decision support (CDS). The MedDMS is also evaluated for real-time recording of CDS data from U-Prevent for cardiovascular risk management and from the Stroke Triage App for prehospital triage.Discussion The MedDMS is discussed in relation to other solutions for privacy-by-design, integrated data stewardship and real-time data analytics in precision medicine.Conclusion LogiqSuite is used for multi-centre research study data registrations and monitoring, data analytics in interdisciplinary consortia, design of new machine learning / artificial intelligence (AI) algorithms, development of new or updated prediction models, integration of care with advanced therapy production, and real-world data monitoring in using CDS tools. The integrated MedDMS application supports data management for care and research in precision medicine.Competing Interest StatementJJLJ, IB, IV, LBR, & SD are employees of ORTEC B.V. which has a commercial interest in LogiqSuite.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Yes (N/A)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesN.A.ABACAttribute-Based Access ControlAIArtificial IntelligenceAMLAcute Myeloid LeukaemiaCAR-TChimeric Antigen Receptor T-CellsCDSClinical Decision SupportDMSData Management SystemeCRFElectronic Case Report FormETLExtract Transform LoadFAIRFindable, Accessible, Interoperable, and ReusableGDPRGeneral Data Protection RegulationGMPGood Manufacturing PracticeIdPIdentity ProviderLAIPLeukaemia-Aberrant Immune PhenotypeMedDMSMedical Data Management SystemMDRMedical Device RegulationMFAMulti-Factor AuthenticationMRDMinimal Residual DiseaseOMOPObservational Medical Outcomes PartnershipPIIPersonal Identifiable InformationRBACRole-Based Access ControlTTPTrusted Third Party